[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

about

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

Item

http://www.wikidata.org/entity/Q53463643

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

@en

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

@nl

type

Item

label

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

@en

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

@nl

prefLabel

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

@en

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

@nl

P1476

[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].

@en

P2093

E Edelmann

http://www.w3.org/2001/XMLSchema#string

K Krüger

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.

The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study.

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.

Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan.

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

Biologic discontinuation studies: a systematic review of methods

Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis.

P2888

s00393-014-1534-5

P304

414-420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00393-014-1534-5

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26085073

http://www.w3.org/2001/XMLSchema#string